NCT06526754Completed
Feasibility Analysis of LCD-SLA 3D Printing Technology for Overall Surgical Planning of Liver Malignant Tumors
Source: ClinicalTrials.gov · Last updated 18 Dec 2024
Brief summary (registry, in English)
This study aims to evaluate the effectiveness of 3D-printed liver models in hepatobiliary surgery planning compared to traditional digital simulations. It is conducted in three phases: 1. Development and validation of 35 3D-printed liver models, focusing on timeliness, cost, precision, and alignment with digital planning tools. 2. Optimization of the 3D reconstruction process using deep learning to enhance model accuracy and efficiency. 3. A retrospective comparative analysis of surgical outcomes in 64 patients, with one group using 3D-printed models and the other using digital simulations for surgical planning.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 64 (actual)
- First submitted
- 19 Jul 2024
- Start date
- 1 Jan 2019
- Primary completion date
- 1 Jan 2024
- Lead sponsor
- Yang Jihong
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT06526754
What you commit to
- Study type: Interventional
- Participants enrolled: 64
- From 1 Jan 2019 to the primary completion date, 1 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous Liver Surgery: Patients with a history of previous liver resection or transplantation
Other illness
- Non-Surgical Candidates: Patients not eligible for surgery due to advanced disease or comorbidities
- Severe Comorbidities: Patients with severe cardiovascular, respiratory, renal, or other systemic diseases
- Uncontrolled Infections: Patients with uncontrolled active infections
Other
- Pregnancy: Pregnant or breastfeeding women
- Inability to Comply: Patients unable to comply with study procedures or follow-up
Who the study is looking for
- Age: Patients aged 18-75 years
- Gender: Both male and female patients
- Diagnosis: Confirmed diagnosis of hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (iCCA), or perihilar cholangiocarcinoma (pCCA)
- Surgical Candidates: Patients who are candidates for hepatectomy
- Liver Function: Patients with adequate liver function (Child-Pugh A or B)
- Informed Consent: Patients who provide written informed consent
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Affiliated Hospital of Hebei University Coordinator of this site? Confirm its status | Baoding | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.